🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.3871
-0.0228 (-5.56%)
At close: Nov 19, 2026, 4:00 PM EST
0.4000
+0.0129 (3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST

Coherus Oncology Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
53.6442.1726.39257.24211.04326.55
53.6442.1726.39257.24211.04326.55
Revenue Growth
44.36%59.81%-89.74%21.89%-35.37%-31.37%
Cost of Revenue
16.1913.818.73158.9970.0857.59
Gross Profit
37.4528.3617.6698.25140.96268.96
Selling, General & Admin
86.2995.9114.88185.62198.48169.71
Research & Development
96.57108.8991.83105.84199.36363.11
Operating Expenses
182.86204.79206.72291.45397.84532.82
Operating Income
-145.41-176.43-189.05-193.2-256.88-263.86
Interest Expense
-9.54-9-10.73-40.54-32.47-22.96
Interest & Investment Income
774.52.81.91.4
Other Non Operating Income (Expenses)
-1.590.013.122.671.92-1.68
EBT Excluding Unusual Items
-149.54-178.42-192.16-228.27-285.53-287.1
Merger & Restructuring Charges
----10--
Asset Writedown
-2.6-4.7-10.6---
Other Unusual Items
-3.36--12.63--6.22-
Pretax Income
-155.5-183.12-215.39-238.27-291.75-287.1
Income Tax Expense
----0.38--
Earnings From Continuing Operations
-155.5-183.12-215.39-237.89-291.75-287.1
Earnings From Discontinued Operations
19.57351.15243.9---
Net Income to Company
-135.94168.0228.51-237.89-291.75-287.1
Net Income
-135.94168.0228.51-237.89-291.75-287.1
Net Income to Common
-135.94168.0228.51-237.89-291.75-287.1
Net Income Growth
-489.41%----
Shares Outstanding (Basic)
142117115947875
Shares Outstanding (Diluted)
142117115947875
Shares Change
22.26%2.26%21.65%21.30%2.89%-9.63%
EPS (Basic)
-0.961.430.25-2.53-3.76-3.81
EPS (Diluted)
-0.961.430.25-2.53-3.76-3.81
EPS Growth
-476.38%----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-173.71-138.51-20.44-174.88-241.12-38.72
Free Cash Flow Per Share
-1.23-1.18-0.18-1.86-3.11-0.51
Gross Margin
69.81%67.24%66.93%38.19%66.79%82.36%
Operating Margin
-271.09%-418.37%-716.41%-75.10%-121.72%-80.80%
Profit Margin
-253.43%398.43%108.03%-92.48%-138.25%-87.92%
Free Cash Flow Margin
-323.85%-328.45%-77.46%-67.98%-114.25%-11.86%
EBITDA
-141.92-172.51-183.78-189.41-253.18-260.4
EBITDA Margin
-264.58%---73.63%-119.97%-79.74%
D&A For EBITDA
3.493.925.283.793.73.45
EBIT
-145.41-176.43-189.05-193.2-256.88-263.86
EBIT Margin
-271.09%---75.10%-121.72%-80.80%
Advertising Expenses
-6.67.410.910.5-
SEC Filings: 10-K · 10-Q